Jonas H. Fagerberg

Jonas H. Fagerberg

Auto-generated profile, based on publicly available information

Jonas H. Fagerberg

Department of Pharmacy, Uppsala University, Uppsala Biomedical Centre, PO Box 580, SE-751 23 Uppsala, Sweden

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2010 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
JFJonas H. Fagerberg
Jonas H. Fagerberg
OTOksana Tsinman
Oksana Tsinman
NSNa Sun
Na Sun
KTKonstantin Tsinman
Konstantin Tsinman
AAAlex Avdeef
Alex Avdeef
CBChristel BERGSTRÖM
Christel BERGSTRÖM

20 June 2012 in Molecular Pharmaceutics
Verified
Journal Article
Open access
JFJonas H. Fagerberg
Jonas H. Fagerberg
YAYassir Al-Tikriti
Yassir Al-Tikriti
GRGert Ragnarsson
Gert Ragnarsson
CBChristel BERGSTRÖM
Christel BERGSTRÖM
Ethanol intake can lead to an unexpected and possibly problematic increase in the bioavailability of druglike compounds. In this work we investigated the effect of ethanol on the apparent solubility and dissolution rate of poorly soluble compounds in simulated intestinal fluid representing a preprandial state. A series of 22 structurally diverse, poorly soluble compounds were measured for apparent solubility and intrinsic dissolution rate (37 °C) in phosphate buffer pH 6.5 (PhB6.5) and fasted state simulated intestinal fluid (FaSSIF, pH 6.5) with and without ethanol at 5% v/v or 20% v/v. The obtained data were used to understand for which molecules ethanol results in an increased apparent solubility and, therefore, may increase the amount of drug absorbed. In FaSSIF20%ethanol 59% of the compounds displayed >3-fold higher apparent solubility than in pure FaSSIF, whereas the effects of 5% ethanol on solubility, in most cases, were negligible. Acidic and neutral compounds were more solubilized by the addition of ethanol than by lecithin/taurocholate aggregates, whereas bases showed a more substance-specific response to the additives in the buffer. The stronger solubilizing capacity of ethanol as compared to the mixed lipid aggregates in FaSSIF was further identified through Spearman rank analyses, which showed a stronger relationship between FaSSIF20%ethanol and PhB6.5,20%ethanol (rS of 0.97) than FaSSIF20%ethanol and FaSSIF (rS of 0.86). No relationships were found between solubility changes in media containing ethanol and single physicochemical properties, but multivariate data analysis showed that inclusion of ethanol significantly reduced the negative effect of compound lipophilicity on solubility. For this data set the higher concentration of ethanol gave a dose number (Do) <1 for 30% of the compounds that showed incomplete dissolution in FaSSIF. Significant differences were shown in the melting point, lipophilicity, and dose profiles between the compounds having a Do < 1 and Do > 1, with the latter having higher absolute values in all three parameters. In conclusion, this study showed that significant effects of ethanol on apparent solubility in the preprandial state can be expected for lipophilic compounds. The results herein indicate that acidic and neutral compounds are more sensitive to the addition of ethanol than to the mixed lipid aggregates present in the fasted intestine.

4 September 2014 in Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
JFJonas H. Fagerberg
Jonas H. Fagerberg
EKEva Karlsson
Eva Karlsson
JUJohan Ulander
Johan Ulander
GHGunilla Hanisch
Gunilla Hanisch
CBChristel BERGSTRÖM
Christel BERGSTRÖM
Purpose To develop predictive models of apparent solubility (Sapp) of lipophilic drugs in fasted state simulated intestinal fluid (FaSSIF) and aspirated human intestinal fluid (HIF). Methods Measured Sapp values in FaSSIF, HIF and phosphate buffer pH 6.5 (PhBpH6.5) for 86 lipophilic drugs were compiled and divided into training (Tr) and test (Te) sets. Projection to latent structure (PLS) models were developed through variable selection of calculated molecular descriptors. Experimentally determined properties were included to investigate their contribution to the predictions. Results Modest relationships between Sapp in PhBpH6.5 and FaSSIF (R2 = 0.61) or HIF (R2 = 0.62) were found. As expected, there was a stronger correlation obtained between FaSSIF and HIF (R2 = 0.78). Computational models were developed using calculated descriptors alone (FaSSIF, R2 = 0.69 and RMSEte of 0.77; HIF, R2 = 0.84 and RMSEte of 0.81). Accuracy improved when solubility in PhBpH6.5 was added as a descriptor (FaSSIF, R2 = 0.76 and RMSETe of 0.65; HIF, R2 = 0.86 and RMSETe of 0.69), whereas no improvement was seen when melting point (Tm) or logDpH 6.5 were included in the models. Conclusion Computational models were developed, that reliably predicted Sapp of lipophilic compounds in intestinal fluid, from molecular structures alone. If experimentally determined pH-dependent solubility values were available, this further improved the accuracy of the predictions.

19 March 2013 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
UTUlrika Tehler
Ulrika Tehler
JFJonas H. Fagerberg
Jonas H. Fagerberg
RSRichard Svensson
Richard Svensson
MLMats Larhed
Mats Larhed
PAPer Artursson
Per Artursson
CBChristel BERGSTRÖM
Christel BERGSTRÖM
Esterification was used to simultaneously increase solubility and permeability of ciprofloxacin, a biopharmaceutics classification system (BCS) class 4 drug (low solubility/low permeability) with solid-state limited solubility. Molecular flexibility was increased to disturb the crystal lattice, lower the melting point, and thereby improve the solubility, whereas lipophilicity was increased to enhance the intestinal permeability. These structural changes resulted in BCS class 1 analogues (high solubility/high permeability) emphasizing that simple medicinal chemistry may improve both these properties.

1 June 2014 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
CBChristel BERGSTRÖM
Christel BERGSTRÖM
Sara AnderssonSara Andersson
Sara Andersson
JFJonas H. Fagerberg
Jonas H. Fagerberg
GRGert Ragnarsson
Gert Ragnarsson
ALAnders Lindahl
Anders Lindahl

28 August 2015 in Therapeutic Delivery
Verified
Journal Article
Closed access
JFJonas H Fagerberg
Jonas H Fagerberg
CBChristel As Bergström
Christel As Bergström
We have explored for which type of compounds biorelevant dissolution profiling in simulated intestinal fluids would accurately predict solubility in human intestinal fluid. In total, 474 solubility values in simulated and aspirated human intestinal fluid for 78 drugs were compiled and analyzed. Significant solubilization in the colloidal structures was obtained in fasted and fed state fluids for drug compounds with a logD(oct)>3. Highly lipophilic compounds with high melting points (Tm > 200 °C) could also be significantly solubilized, but typically such compounds had solubility values in the lower µg/ml range also in the presence of the colloidal structures. On the basis of our analysis, compounds with a logD(oct)>3 should be explored in biorelevant dissolution media to better predict in vivo performance after oral dosing.